(A) Representative TEM images of mitochondria (‘M’) in contact with ER (pseudocoloured blue) in untreated and CCCP-treated U2OS:GFP-parkin cells. Scale bars, 500 nm. (B–E) Quantification of TEM from …
Numerical source data for Figure 1B–1D, E, I, J and N and Figure 1—figure supplement 1B to D.
(A) Representative TEM image of an untreated U2OS:GFP-parkin WT cell highlighting ER-OMM distances of less than 100, 50 and 25 nm. Intermembrane distances (d) are indicated. Scale bars, 500 and 100 …
(A) Immunoblot analysis of protein turnover in glucose-maintained U2OS:GFP-parkin WT and A320R cells treated with 20 μM CCCP for the indicated time. (B) Higher exposures of Mfn2 and TOM20 …
(A) Base peak chromatograms indicating equal loading of both DMSO- and CCCP-treated samples from Figure 2F and G. (B) Extracted ion chromatograms of the indicated Ub and Mfn2 peptides from both …
(A) Immunoblot analysis of whole-cell lysates from cells cultured in glucose or galactose transfected with control siRNA or siRNA targeting Mfn1 (‘siMfn1’) or Mfn2 (‘siMfn2’). (B) Mitochondrial …
Numerical source data for Figure 3D, E and G, Figure 3—figure supplement 1B–D, Figures 2B, 3C, D, H, I, 4F, H and 5C.
(A) Representative TEM images of U2OS:GFP-parkin cells transfected with the indicated siRNA. ER tubules are pseudocoloured blue. Scale bar, 500 nm. (B–D) Quantification of mitochondrial length (B), …
(A) Representative confocal images of U2OS:GFP-parkin (green) cells, grown on either glucose or galactose, treated with 20 μM CCCP for the indicated times. Cells were then fixed and stained for …
(A) Immunoblot analysis of whole-cell lysates from cells cultured in glucose or galactose transfected with control siRNA or siRNA targeting Mfn1 (‘siMfn1’), Mfn2 (‘siMfn2’) or both mitofusins …
(A) Genomic sequence of human Mfn2 (exon 3) that was mutated in U2OS cells using CRISPR/Cas9. The arrow indicates the codon corresponding to methionine-1; leucine-29 (‘L29’), lysine-30 (‘K30’) and …
(A) Immunoblot analysis of PINK1 depletion in WT and Mfn2 KO (clone A4) U2OS cells treated with 20 μM CCCP for four hours. The arrowhead indicates the PINK1 band, while the asterisk indicates a …
(A) Mfn2 KO:YFP-parkin WT cells were transfected with the indicated plasmid and CFP in a 3:1 ratio, then fixed and immunostained for TOM20 (red) and counterstained with Hoechst 33342 (blue). Scale …
Numerical source data for Figure 4C, F, G and K.
(A) Sequence alignment of sites of Mfn2 modification across species. Ubiquitinated lysines and phosphorylated serines and threonines are indicated by arrowheads. Residue numbering is according to …
(A) Immunoblot analysis of NP-40-solubilized mitochondria, isolated from U2OS:GFP-parkin WT cells treated with 20 μM CCCP for the indicated time, separated by blue native- (BN-) and SDS-PAGE. (B, C) …
Numerical source data for Figure 5G and H.
(A) Representative confocal images of p97 recruitment to mitochondria in cells treated with 20 μM CCCP and/or 25 μM NMS-873 for the indicated time. Blue asterisks denote cells with mitochondrial …
Numerical source data for Figure 6I and K and Figure 6—figure supplement 1C.
(A) Workflow of protein purification, phosphorylation, pull-down and LC/MS. GST-4xUb G76V, which cannot be cleaved by the cellular Ub processing machinery, was phosphorylated on S65 by Tribolium …
(A) U2OS:mtKeima cells were transfected with the indicated siRNA and GFP-parkin WT, and were treated with 20 μM CCCP (or DMSO) for five hours in the presence (dark grey box) or absence (light grey …
Numerical source data for Figure 7B, D–F and H.
(A) Workflow for the in organello ubiquitination assay, where HeLa cells are depolarized with 20 μM CCCP for four hours and mitochondria are isolated (‘mitoCCCP’, with control ‘mitoDMSO’). These are …
Numerical source data for Figure 8K.
In organello ubiquitination reactions were performed in the presence or absence of 25 μM NMS-873. Reactions were incubated on ice for 30 min prior to a 60 min 37°C incubation. In the immunoblot …
(A) PINK1-phosphorylated Ub on Mfn2 initially recruits parkin to Mfn2 complexes, where it is phosphorylated and activated by PINK1. (B) Parkin and PINK1 cooperate to catalyze a pUb burst on Mfn2. (C)…
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
cell line (Homo sapiens) | U2OS | PMID 24446486 | ||
cell line (Hs) | U2OS:GFP | PMID 24446486 | ||
cell line (Hs) | U2OS:GFP-parkin WT | PMID 24446486 | ||
cell line (Hs) | U2OS:GFP-parkin A320R | PMID 28276439 | ||
cell line (Hs) | Mfn2 KO | this paper | see Plasmids and transfection | |
cell line (Hs) | Mfn2 KO:YFP-parkin WT | this paper | see Plasmids and transfection | |
cell line (Hs) | Mfn2 KO:YFP-parkin C431S | this paper | see Plasmids and transfection | |
cell line (Hs) | HeLa | PMID 24446486 | ||
cell line (Hs) | control-1 | NIH | NCRM-1 | |
cell line (Hs) | control-2 | PMID 27641647 | ||
cell line (Hs) | PRKN(del) | PMID 20885945 | ||
transfected construct (Hs) | HA-Ub | PMID 25216678 | ||
transfected construct (Hs) | DsRed2-LC3 | PMID 18596167 | ||
transfected construct (Hs) | Mfn1-HA | PMID 15878861 | ||
transfected construct (Hs) | Mfn2 WT | PMID 15878861 | ||
transfected construct (Hs) | Mfn2 K406R | this paper | see Plasmids and transfection | |
transfected construct (Hs) | Mfn2 K416R | this paper | see Plasmids and transfection | |
transfected construct (Hs) | Mfn2 K420R | this paper | see Plasmids and transfection | |
transfected construct (Hs) | Mfn2 HR1 | this paper | see Plasmids and transfection | |
transfected construct (Hs) | Mfn2 HR2 | this paper | see Plasmids and transfection | |
transfected construct (Hs) | Mfn2 TS/AA | this paper | see Plasmids and transfection | |
transfected construct (Hs) | GFP-parkin WT | PMID 24446486 | ||
biological sample (Mus musculus) | parkin WT brain cytosol | this paper | see In organello ubiquitination assays | |
biological sample (Mm) | parkin KO brain cytosol | this paper | see In organello ubiquitination assays | |
antibody | anti-actin | Millipore | MAB1501 | |
antibody | anti-B-III-tubulin | Sigma | T8660 | |
antibody | anti-MAVS | Enzo | ALX-210–929 C100 | |
antibody | anti-cytochrome c | BD | 556432 | |
antibody | anti-GFP | Abcam | ab6673 | IP |
antibody | anti-GFP | Invitrogen | A6455 | WB |
antibody | anti-Grp78 | Santa Cruz | sc-376768 | |
antibody | anti-HA | Abcam | ab9134 | |
antibody | anti-HK1 | Cell Signaling | 2024S | |
antibody | anti-Mfn1 | Santa Cruz | sc-50330 | |
antibody | anti-Mfn2 | Sigma | M6319 | WB in Figure 3—figure supplement 2D |
antibody | anti-Mfn2 | Cell Signaling | 9482 | all other assays (IF, WB, IP) |
antibody | anti-CIV-COXI | Abcam | ab14705 | |
antibody | anti-p62 | Progen | GP62-C | |
antibody | anti-PDH E1a | Abcam | ab110330 | |
antibody | anti-PDH E2/E3bp | Abcam | ab110333 | |
antibody | anti-PDI | Abcam | ab2792 | |
antibody | anti-PINK1 | Cell Signaling | 6946 | |
antibody | anti-pS65 Ub | Millipore | ABS1513-I | |
antibody | anti-Rab11A | Cell Signaling | 2413 | |
antibody | anti-Miro1 | Sigma | HPA010687 | |
antibody | anti-CII-SDHA | Abcam | ab14715 | |
antibody | anti-Stx17 | ProteinTech | 17815–1-AP | |
antibody | anti-TH | Pel-Freez | P40101-150 | |
antibody | anti-TIM23 | BD | 611222 | |
antibody | anti-TOM20 | Santa Cruz | sc-11414 | |
antibody | anti-TOM70 | Santa Cruz | sc-390545 | |
antibody | anti-Ub [FK2] | Enzo | BML-PW8810 | IF |
antibody | anti-Ub [P4D1] | Santa Cruz | sc-8017 | WB |
antibody | anti-CIII-core2 | Abcam | ab14745 | |
antibody | anti-CIII-Rieske | Abcam | ab14746 | |
antibody | anti-p97 | Abcam | ab11433 | |
antibody | anti-VDAC1 | Abcam | ab14734 | |
recombinant protein (Rattus norvegicus) | GST-R0RBR WT | PMID 23661642 | ||
recombinant protein (Rn) | GST-R0RBR A320R | this paper | see Plasmids and transfection | |
recombinant protein (Rn) | GST-parkin WT | PMID 28276439 | ||
recombinant protein (Rn) | GST-parkin C431A | PMID 28276439 | ||
recombinant protein (Hs) | UbcH7 | PMID 28276439 | ||
recombinant protein (Hs) | UBE1 | BostonBiochem | E-305 | |
recombinant protein (Hs) | Ubiquitin | BostonBiochem | U-100H | |
recombinant protein (Hs) | Usp2 catalytic domain | BostonBiochem | E-504 | |
recombinant protein (Tribolium castaneum) | TcPINK1 | PMID 24784582 | ||
recombinant protein (Hs) | GST-4xUb G76V | PMID 23670163 | ||
recombinant protein (Mm) | His-p97 | PMID 19506019 | ||
commercial assay or kit | QuikChange II site-directed mutagenesis kit | Agilent | 200523 | |
commercial assay or kit | BCA protein assay | ThermoFisher | 23227 | |
chemical compound, drug | CCCP | Sigma | C2759 | |
chemical compound, drug | MG132 | Sigma | M8699 | |
chemical compound, drug | Hoechst 33342 | ThermoFisher | H3570 | |
chemical compound, drug | NMS-873 | ApexBio | B2168 | |
software, algorithm | BioTools | Bruker | ||
software, algorithm | MASCOT | Matrix Science | ||
software, algorithm | Data Analysis | Bruker | ||
software, algorithm | ImagJ | NIH | ||
software, algorithm | PyMOL | Schrodinger | ||
software, algorithm | Excel | Microsoft | ||
software, algorithm | Prism | GraphPad |
MS identification of selective Ub and pUb interactors.
Table depicting GST-4xUb interactors that are selective for S65-phosphorylated (top) or unphosphorylated (bottom) Ub. p97-related data (shaded in yellow) are also depicted in Figure 6—figure supplement 1C.